Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study
Влияние синбиотиков на микробиоту кишечника в раннем возрасте: рандомизированное двойное слепое исследование
2021-02-11
SCID: 54.1/2szht5yr
Discuss with AI
Bifidobacterium breve M-16VClostridioides difficileinfant gut microbiotascGOS/lcFOSsynbiotic supplementation
Figures from the paper
Abstract (AI)
Abstract Human milk is considered the optimal nutrition for infants and found to contain significant numbers of viable bacteria. The aim of the study was to assess the effects of a specific synbiotic combination at doses closer to the bacterial cells present in human milk, on intestinal bifidobacteria proportions (relative abundance), reduction of potential pathogens and gut physiological conditions. A clinical study was conducted in 290 healthy infants aged from 6 to 19 weeks. Infants received either a control infant formula or one of the two investigational infant formulas (control formula with 0.8 g/100 ml scGOS/lcFOS and Bifidobacterium breve M-16V at either 1 × 10 4 cfu/ml or 1 × 10 6 cfu/ml). Exclusively breastfed infants were included as a reference. Analyses were performed on intention-to-treat groups and all-subjects-treated groups. After 6 weeks of intervention, the synbiotics at two different doses significantly increased the bifidobacteria proportions in healthy infants. The synbiotic supplementation also decreased the prevalence (infants with detectable levels) and the abundance of C. difficile . Closer to the levels in the breastfed reference group, fecal pH was significantly lower while l -lactate concentrations and acetate proportions were significantly higher in the synbiotic groups. All formulas were well tolerated and all groups showed a comparable safety profile based on the number and severity of adverse events and growth. In healthy infants, supplementation of infant-type bifidobacterial strain B. breve M-16V, at a dose close to bacterial numbers found in human milk, with scGOS/lcFOS (9:1) created a gut environment closer to the breastfed reference group. This specific synbiotic mixture may also support gut microbiota resilience during early life. Clinical Trial Registration This clinical study named Color Synbiotics Study, was registered in ClinicalTrials.gov on 18 March 2013. Registration number is NCT01813175. https://clinicaltrials.gov/ct2/show/NCT01813175 .
Key Findings
1
All formulas were well tolerated, with comparable adverse-event profiles and growth across groups.
2
In 290 healthy infants aged 6–19 weeks, both tested doses of Bifidobacterium breve M-16V with scGOS/lcFOS significantly increased fecal bifidobacteria proportions after six weeks.
3
Synbiotic groups had lower fecal pH and higher L-lactate concentrations and acetate proportions, approaching values observed in exclusively breastfed reference infants.
4
Synbiotic supplementation reduced both the prevalence of detectable Clostridioides difficile and its abundance compared with control formula.
5
The specific synbiotic combination created an intestinal environment more similar to that of breastfed infants and may support gut microbiota resilience during early life.
Research Object
Gut microbiota and intestinal physiological conditions in healthy infants during early life
Research Subject
Effects of scGOS/lcFOS and Bifidobacterium breve M-16V synbiotic supplementation on bifidobacteria proportions, potential pathogen levels, fecal pH, lactate and acetate, and gut microbiota resilience
Publication Details
Publication Date
2021-02-11
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula2005
Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life2005
Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development2017
The Bifidogenic Effect Revisited—Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life2020